Sansum Diabetes Research Institute Attracts World Renowned Diabetes Expert as Research Director United Kingdom's Dr. David Kerr to serve the Santa Barbara-based Institute in advancing the artificial pancreas program and diabetes treatment protocols
SANTA BARBARA, Calif., Jan. 31, 2014 /PRNewswire/ -- Sansum Diabetes Research Institute is pleased to announce the appointment of Dr. David Kerr MD FRCPE, as the Director of Diabetes Research and Innovation.
Dr. Kerr was formerly the Consultant Physician and Endocrinologist at the Bournemouth Diabetes and Endocrine Centre in the United Kingdom, Honorary Senior Lecturer at the University of Southampton, and Visiting Professor at Bournemouth University. He is a Fellow of the Royal College of Physicians of Edinburgh and for a number of years has held a Gold Clinical Excellence Award from the UK National Health Service (NHS).
"We are tremendously honored to have Dr. Kerr, his experience, and highly acclaimed expertise," said Rem Laan, Executive Director for Sansum Diabetes Research Institute. "Dr. Kerr is passionate about diabetes care, with a particular interest in the use of technology to support people living with type 1 and type 2 diabetes. His amiable nature will fit in well with the Institute and the community."
In his position, Dr. Kerr will lead the diabetes research activities of the Institute, including research in artificial pancreas and pregnancy complicated by diabetes, two areas for which the Institute is internationally distinguished. In addition, Dr. Kerr will continue to pursue his research in the application of technology for diabetes care and the use of new methods of communications, including social media, to reduce the day-to-day decision-making burden for people living with diabetes, wherever they live.
"Hiring Dr. Kerr continues the Institute's trajectory of substantial and impactful innovation in diabetes research," says Dr. Robert Nagy, Institute Board President. "His role with the Institute ensures that we will continue to be at the global forefront of diabetes treatment just as Dr. Sansum intended more than 70 years ago."
Dr. Kerr is and will continue as Editor of Diabetes Digest in the UK and board member of the Journal of Diabetes Science and Technology. Recently he has also created free online resources, www.VoyageMD.com and www.Excarbs.com, the former dedicated to travel and diabetes and the latter focusing on exercise and insulin, as well as launching a smartphone app for people with diabetes complicated by painful neuropathy. Currently, Dr. Kerr is also working with the Diabetes Technology Society to create a certification program for health care professionals from outside of the U.S. in the area of diabetes and technology.
Dr. Kerr graduated from Aberdeen University in Scotland in 1981. After completing his specialist medical training in internal medicine, diabetes and endocrinology, he spent two years in the Division of Endocrinology at Yale University in the United States before being appointed to lead the diabetes clinical service in Bournemouth in 1992. You can follow him on Twitter: @GoDiabetesMD.
ABOUT SANSUM DIABETES RESEARCH INSTITUTE:
Our singular daily focus is to improve the health and quality of life of men, women and children in Santa Barbara County - and millions around the world - who suffer from diabetes. We have been on the cutting edge of diabetes research, clinical care, and education since our founding in 1944 by Dr. William Sansum, the first U.S. physician to administer insulin in the treatment of diabetes.
Sansum Diabetes Research Institute advances new technologies and produces groundbreaking diabetes treatments, such as the development of an artificial pancreas that enables the automated delivery of insulin to patients. Understanding that diet and lifestyle factors are key to the effective management and prevention of diabetes, the Institute offers education to the more than 40,000 Santa Barbara County residents impacted by the disease. The Institute also provides direct clinical care to patients, like pregnant mothers with gestational diabetes, helping them to deliver healthy babies.
SOURCE Sansum Diabetes Research Institute